Century Therapeutics Inc (NQ: IPSC )
3.240 +0.060 (+1.89%) Streaming Delayed Price Updated: 1:47 PM EDT, Jun 1, 2023 Add to My Watchlist
Headline News about Century Therapeutics Inc
Century Therapeutics: Q1 Earnings Insights
May 11, 2023
Analyst Ratings for Century Therapeutics
April 13, 2023
Century Therapeutics's Return On Capital Employed Overview
March 20, 2023
Where Century Therapeutics Stands With Analysts
March 16, 2023
8 Analysts Have This to Say About Century Therapeutics
January 06, 2023
Benzinga's Top Ratings Upgrades, Downgrades For December 27, 2022
December 27, 2022
Stocks That Hit 52-Week Lows On Thursday
January 12, 2023
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Gamma Delta T Cell Therapy Market Could Reach $4 Billion As Biotechs Race To Get Breakthrough Cancer Treatment Approved
November 22, 2022
This year, the World Health Organization (WHO) announced that cancer has become the leading cause of death worldwide, with the latest data showing that nearly 10 million deaths in 2020 were the result...
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 25, 2022
FDA Announced Clearance To Century Therapeutics' Allogeneic Cell Therapy Candidate Study
August 25, 2022
Century Therapeutics, Inc. (NASDAQ: IPSC) received ELiPSE-1 clinical study may proceed notification from the U.S. Food and Drug Administration (FDA) to assess CNTY-101 in patients with relapsed or...
U.S. Stock Futures Higher Following Friday's Rally
June 27, 2022
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
February 08, 2022
Natural-killer cell therapy is one of the most recent paradigms in cancer treatment, and two prominent companies working on this new technology are Fate Therapeutics Inc (NASDAQ: FATE) and Century...
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following